Related references
Note: Only part of the references are listed.
Article
Pharmacology & Pharmacy
Zhaoyun Liu et al.
Summary: The use of magnetic nanocomposites for controlled drug release and target-specific delivery has great potential in cancer chemotherapy. This study developed an efficient magnetic nanostructure for tumor cell inhibition, demonstrating good biocompatibility and controlled drug release properties.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
(2023)
Article
Biochemistry & Molecular Biology
Liu Cui et al.
Summary: Stimulus-responsive nanomaterials have shown promise in controllable drug delivery systems for cancer therapy. In this study, iron (III) carboxylate metal-organic framework nanoparticles coated with glycyr- rhetinic acid-chitosan conjugate were successfully fabricated as a pH-responsive and target-selective system for delivering doxorubicin to hepatocellular carcinoma cells. The nanocarriers exhibited uniform size, high drug loading efficiency, and pH-dependent controlled drug release. In vitro experiments demonstrated their excellent inhibitory effects on cancer cells and targeted delivery ability. The results suggest that these nanoparticles have potential applications in cancer therapy as a pH-responsive controlled drug delivery system.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
(2023)
Article
Chemistry, Physical
Xi Wang et al.
Summary: A magnetic liposome-based dual-targeting delivery system was designed for the treatment of idiopathic pulmonary fibrosis (IPF), effectively delivering dexamethasone (Dex) into M2 macrophages in the lung to inhibit the progression of IPF. The mannose-modified magnetic nanoparticles were loaded on the surface of liposomes, allowing recognition and internalization by M2 macrophages in situ under the influence of a static magnetic field (SMF). The reduction of M2 macrophages and inhibition of their polarization led to a decrease in α-SMA expression and collagen deposition, demonstrating the effectiveness of this novel therapeutic system for IPF treatment.
JOURNAL OF COLLOID AND INTERFACE SCIENCE
(2023)
Article
Nanoscience & Nanotechnology
Sijin Chen et al.
Summary: In this study, a strategy to block the redox systems and enhance ferroptotic cancer cell death was reported using a layered double hydroxide (LDH) nanoplatform. The nanoplatform, siR/IONs@LDH, can efficiently release iron oxide nanoparticles (IONs) and DHODH inhibitor (siR) in a pH-responsive manner, generate toxic reactive oxygen species (ROS) via a Fenton reaction, and synergistically induce cancer cell death by promoting lipid peroxidation accumulation. In vivo therapeutic evaluations demonstrated excellent tumor growth inhibition by the nanomedicine without detectable side effects. This study provides new insights into nanomaterial-mediated tumor ferroptosis therapy.
ACS APPLIED MATERIALS & INTERFACES
(2023)
Review
Biophysics
Shalvi Sinai Kunde et al.
Summary: This review summarizes the development of albumin nanoparticles for chemotherapeutic drug delivery and their targeted approach for breast cancer. The article also introduces the multifunctional therapies available using albumin nanoparticles as a treatment and diagnostic method for breast cancer.
COLLOIDS AND SURFACES B-BIOINTERFACES
(2022)
Review
Pharmacology & Pharmacy
Pedram Ebrahimnejad et al.
Summary: Targeted nanocarriers, modified with folate ligands, can deliver drugs to cancer cells at the right time and reduce drug doses to minimize side effects. This review highlights the latest developments and discusses the toxicity, biocompatibility, and efficacy of folate-conjugated nanoparticles in cancer diagnosis and treatment.
DRUG DISCOVERY TODAY
(2022)
Article
Chemistry, Physical
Shige Wang et al.
Summary: This research proposes the one-pot preparation of polydopamine (PDA) decorated mesoporous silica nanoparticle (PMSN) for the thermal and tumor micro-environment (TME) responsive colorectal tumor therapy. The PMSN pores were utilized for loading Fe3+. Lauric acid (LA) was selected as a phase-change ligand to coat the surface of Fe3+-loaded PMSN and prevent the leakage of Fe3+. Bovine serum albumin (BSA) was chosen as a stabilizer to provide colloidal stability for the PMSN-Fe-LA-BSA nanopartilces (PMFLB). Under near infrared laser, the light-sensitive PDA generated heat to kill colorectal cancer cells via hyperthermia. The heat induced the phase-change of LA and triggered the release of Fe3+, which reacted with endogenous H2S in the colorectal TME. The transformed Fe3+ into Fe2+ then initiated the Fenton reaction with H2O2, generating hydroxyl radical (•OH). The Fe2+ was converted back to Fe3+, which further reacted with H2S to enhance the chemodynamic therapy of colorectal tumor. The thermosensitive PMFLB that operates in synergy with the colorectal TME offers a new approach for the rational design of multifunctional nano-therapeutic agents.
JOURNAL OF COLLOID AND INTERFACE SCIENCE
(2022)
Review
Pharmacology & Pharmacy
Pearl Moharil et al.
Summary: Combining passive targeting with active targeting is a promising approach to improve the therapeutic efficacy of nanotherapy. In this study, ultra-small-sized gemcitabine-based nanoparticles were combined with folic acid conjugation for enhanced dual targeted delivery to tumor cells and tumor-associated macrophages. The co-delivery system showed small particle size and achieved significant reduction of tumor growth in a breast cancer model.
ACTA PHARMACEUTICA SINICA B
(2022)
Review
Pharmacology & Pharmacy
Ranjith Kumar Kankala
Summary: Pristine layered double hydroxides (LDHs) have limitations in biomedicine, but these can be overcome by fabricating nanocomposites. This article highlights the limitations of pristine LDHs and the engineering strategies for different LDHs-based nanocomposites, and provides a detailed explanation of their performance efficacy in various biomedical applications.
ADVANCED DRUG DELIVERY REVIEWS
(2022)
Review
Oncology
Eesha Chakraborty et al.
Summary: Primary liver cancer is a major global health challenge with a significant negative impact on patient survival. Conventional cancer treatments are often ineffective due to the resistance of liver cancer. This review explores new and advanced therapies, such as gene therapy and immunotherapy, as potential breakthroughs for more effective and safer treatment.
Review
Pharmacology & Pharmacy
Quan Gao et al.
Summary: This article discusses the synergistic anticancer effects and related mechanisms of combined therapy using chemotherapeutic drugs and natural compounds, aiming to enhance the efficacy of cancer treatment and reduce adverse consequences. In addition, the design and application of nano drug delivery systems for co-delivery of drugs can also improve anticancer efficacy.
ADVANCED DRUG DELIVERY REVIEWS
(2022)
Review
Chemistry, Multidisciplinary
Tingting Hu et al.
Summary: In this review, the applications of layered double hydroxides (LDHs) in the field of biomedicine are comprehensively summarized. The preparation and surface modification methods of LDH-based nanomaterials are discussed, and the potential of LDHs in drug delivery, bioimaging, and cancer therapy are described. The remaining challenges and future prospects in this rapidly emerging field are also discussed.
CHEMICAL SOCIETY REVIEWS
(2022)
Review
Oncology
Josep M. Llovet et al.
Summary: In this article, Llovet and colleagues review recent advances in hepatocellular carcinoma therapy and discuss the clinical workflows for selecting and monitoring patients. The article covers the molecular pathogenesis of HCC, molecular classes and determinants of heterogeneity, and effective systemic therapies including immunotherapy. The authors propose a flowchart of sequential therapies, explore mechanisms of resistance, and address the need for predictive biomarkers.
Article
Chemistry, Multidisciplinary
Changyu Cao et al.
Summary: A novel all-in-one Fe3O4/Ag/Bi2MoO6 nanoparticle (FAB NP) is designed for synergistic chemodynamic, photodynamic, and photothermal therapy in the tumor microenvironment, demonstrating outstanding therapeutic outcomes. The mechanisms of intraparticulate interactions, sustainability, and self-replenishment are carefully revealed, providing new insights into the design of novel nanozymes for efficient nanocatalytic therapy with high specificity and low side effects.
ADVANCED MATERIALS
(2021)
Review
Pharmacology & Pharmacy
Vikas Kumar et al.
Summary: Hepatocellular carcinoma is a major health issue worldwide, with traditional therapies showing sub-optimal responses. Nanomedicine has attracted attention for its target-specific drug delivery and minimal toxicity.
EXPERT OPINION ON DRUG DELIVERY
(2021)
Article
Oncology
Hyuna Sung et al.
Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.
CA-A CANCER JOURNAL FOR CLINICIANS
(2021)
Review
Pharmacology & Pharmacy
Magdalena Jurczyk et al.
Summary: Cancer treatment is a major challenge globally, with nanoparticle drug delivery systems playing a crucial role in avoiding the side effects of traditional chemotherapy. Future nanomedicine should focus on active targeting and dual-targeting systems for better efficacy in cancer therapy.
Review
Chemistry, Multidisciplinary
Xue Shen et al.
Summary: Nanovehicles based on serum albumin have gained significant attention in the field of cancer treatment, thanks to their biocompatibility, stability, ease of preparation, and multifunctionality. These nanovehicles show great potential in cancer diagnosis and therapy, offering various strategies and types for drug delivery and treatment of the disease.
FRONTIERS IN CHEMISTRY
(2021)
Review
Oncology
Raghuraj Singh Chouhan et al.
Summary: This review discusses the selective targeting of magnetic nanoparticles for various solid tumors through surface modification, highlighting the remarkable properties of iron oxide nanoparticles for biomedical applications. The synthesis, surface modification, and diverse applications of iron oxide nanoparticles for diagnosis, imaging, therapy, enzyme mimetic compounds, and contrasting agents are also emphasized.
Article
Nanoscience & Nanotechnology
Thuy Giang Nguyen Cao et al.
Summary: Utilizing exosomes as nanocarriers, this study effectively delivered the sonosensitizer ICG to tumor tissues, with surface modification using the cancer-targeting ligand FA to enhance ROS production in breast cancer cells and inhibit tumor growth. The active cancer-targeted FA-ExoICG showed superior tumor accumulation, pharmacokinetic properties, and sonotoxicity against cancer cells compared to ExoICG and free ICG, demonstrating its potential as an effective nanosonosensitizer for safe and targeted cancer treatment.
ACS APPLIED MATERIALS & INTERFACES
(2021)
Article
Engineering, Environmental
Ping Wang et al.
Summary: The development of a biomimetic nano-catalyst based on a TiO2/Fe3O4 platform shows promising therapeutic performance in inhibiting tumor growth by inducing a cascade of biochemical reactions to produce OH radicals in the tumor microenvironment.
CHEMICAL ENGINEERING JOURNAL
(2021)
Article
Chemistry, Multidisciplinary
Jianping Liu et al.
Summary: A novel nanomedicine has been developed for combination breast cancer therapy, which shows high efficacy in nearly eliminating tumors with minimal side effects.
JOURNAL OF CONTROLLED RELEASE
(2021)
Article
Materials Science, Multidisciplinary
Shuhui Wang et al.
Summary: The multifunctional nanoprobe based on Au nanostars@PDA@Fe3O4 showed promising results in tumor targeted imaging and photothermal therapy. The unique structure of the nanoprobe exhibited low photothermal conversion threshold and increased photothermal efficiency by 50%. Under the guidance of multimodal imaging, homogeneous photothermal ablation of bulky solid tumors was achieved.
MATERIALS & DESIGN
(2021)
Review
Biochemistry & Molecular Biology
David Anwanwan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
(2020)
Review
Oncology
Manali Dimri et al.
Review
Engineering, Biomedical
Ali Farzin et al.
ADVANCED HEALTHCARE MATERIALS
(2020)
Review
Oncology
Mariana Scaranti et al.
NATURE REVIEWS CLINICAL ONCOLOGY
(2020)
Article
Materials Science, Biomaterials
Mina Ahmadi-Kashani et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
(2020)
Article
Medicine, Research & Experimental
Ni Zhang et al.
Review
Gastroenterology & Hepatology
Peter R. Galle et al.
LIVER INTERNATIONAL
(2019)
Review
Gastroenterology & Hepatology
Ju Dong Yang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY
(2019)
Review
Materials Science, Multidisciplinary
Meiwan Chen et al.
Review
Chemistry, Multidisciplinary
Yong Hu et al.
CHEMICAL SOCIETY REVIEWS
(2018)
Review
Chemistry, Multidisciplinary
Marcos Fernandez et al.
Article
Chemistry, Multidisciplinary
David Chimene et al.
ADVANCED MATERIALS
(2015)
Article
Chemistry, Multidisciplinary
Yu Luo et al.
Article
Materials Science, Biomaterials
Zi Gu et al.
JOURNAL OF MATERIALS CHEMISTRY B
(2015)
Article
Pharmacology & Pharmacy
Conghui Chen et al.
JOURNAL OF DRUG TARGETING
(2015)
Article
Chemistry, Multidisciplinary
ZP Xu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
(2006)
